A B S T R A C T The role of calmodulin in insulin secretion from rat pancreatic islets has been examined by the use of trifluoperazine, an inhibitor of calmodulin-Ca++-directed functions. It was found that 30 ,M trifluoperazine caused 50% inhibition, and 100 ,M, up to 73% inhibition of 16.7 mM glucosestimulated insulin release. 100 ,M trifluoperazine caused a similar inhibition of 10 mM glyceraldehydestimulated release. Therefore, the site of action of trifluoperazine in glucose stimulus-secretion coupling appears to be after the trioses. As trifluoperazine had no effect upon insulin release stimulated by 1 mM 3-isobutyl-1-methylxanthine, the inhibitory effect of trifluoperazine appears to be rather specific. Further, the process of exocytosis per se is not affected. It was also found that although trifluoperazine inhibited the effect of glucose to stimulate insulin release, it did not affect the synergism between glucose and 3-isobutyl-1-methylxanthine to potentiate insulin release. It may be concluded that trifluoperazine selectively inhibits one part of the mechanism by which glucose stimulates insulin release. Calmodulin plays a role in the stimulation of insulin release by glucose at a site between metabolism of trioses and elevation of cytosol Ca+ but is not involved in the final process of exocytosis.
INTRODUCTION
Glucose exerts a major controlling influence over the rate of insulin secretion. A rise in the cytosolic concentration of ionized calcium is considered to be an important factor in stimulus-secretion coupling (1) (2) (3) (4) , but the mechanism by which Ca++ induces exocytosis and insulin secretion is unknown. However, calciumdependent modulator proteins, such as calmodulin, are Received for publication 26 April 1980 and in revised form 4 June 1980. known to mediate some Ca++-stimulated processes (5, 6) . Calmodulin is present in islets and has been shown to activate adenylate cyclase from islets (7) (8) (9) . It seems important, therefore, to evaluate the possible role of calmodulin in the regulation of insulin secretion. As a first step, the effects of trifluoperazine, a specific inhibitor of the calmodulin-Ca++ complex (10) , have been examined with respect to various stimulators of insulin secretion.
METHODS
Preparation and incubation of islets. Pancreatic islets were isolated from fed male Wistar rats by collagenase digestion (11) . After a 30-min preincubation at 37°C in Krebs-Ringer bicarbonate buffer containing 10 mM Hepes buffer, 0.5% bovine serum albumin, and 2.8 mM glucose, groups of20 islets were incubated in 500 A1 ofthe same buffer, but with 2.8 or 16.7 mM glucose and the test substances as appropriate. After 30 min, the supernates were removed for insulin radioimmunoassay (12) (10) and thereby inhibit the activity of various calmodulin-sensitive enzymes (14) . The Ca++-dependent binding of trifluoperazine to a variety of proteins (10); (b) the fact that the inhibitory effects of trifluoperazine are related to the presence of Ca++ in concentrations that are required for activation of calmodulin-sensitive enzymes (10); and (c) the fact that the inhibitory effects of trifluoperazine and other phenothiazines are correlated with their binding affinities to calmodulin (15) . The results of the studies presented here, and of others, which demonstrate an inhibition of glucosestimulated insulin release by trifluoperazine and the presence of calmodulin in islets (7), indicate the possible involvement of calmodulin in the mechanism of stimulus-secretion coupling. Trifluoperazine inhibited glyceraldehyde-and glucose-stimulated insulin release to the same extent, and this suggests that the calmodulin-sensitive step does not occur before trioses in glucose metabolism. It is important to note the complete absence of an inhibitory effect of trifluoperazine upon IBMX-induced release, because this strongly suggests that calmodulin is not involved in the process of exocytosis per se. In fact, as IBMX is thought to stimulate insulin release by raising cyclic AMP levels and mobilizing intracellular Ca++ stores to raise cytosol Ca++ (16) , then all the steps between elevation of cytosol Ca++ and exocytosis appear to be independent of calmodulin. Further, the mobilization of Ca++ by IBMX is calmodulin independent. It was found that trifluoperazine had the same inhibitory effect on insulin release in the presence of IBMX at 16.7 mM glucose as it did with 16.7 mM glucose alone. Thus the action of IBMX was unaffected by trifluoperazine whether in the presence of low or high glucose concentrations. This leads to the striking conclusion that the potentiation of insulin release was the same in the presence and absence of trifluoperazine and that the synergism between glucose and IBMX is preserved at a time when the stimulation of insulin release by glucose is inhibited. This conclusion suggests that glucose potentiates the effect of IBMX, not that IBMX potentiates the effect of glucose, and that the mechanism ofpotentiation is unaffected by trifluoperazine and is therefore calmodulin insensitive.
The mechanisms underlying the observed effects of trifluoperazine are unknown. It is to be expected that inhibition of calmodulin-directed processes, because of their multiplicity, would lead to multiple effects. In islets this is manifested by (a) inhibition of glucose and glyceraldehyde-stimulated insulin release, and (b) a small stimulation of insulin release under basal conditions. Enzyme systems known to be sensitive to calmodulin, which if inhibited by trifluoperazine would lead to inhibition of insulin release, include adenylate cyclase and protein kinase. Activation of adenylate cyclase by Ca++-calmodulin may underlie the Ca++-dependent increase in cyclic AMP observed in islets exposed to glucose (17) (18) (19) , as suggested by the presence of Ca++-calmodulin-dependent adenylate cyclase in islets (8, 9) . Inhibition of the cyclic AMP response to glucose by trifluoperazine can be expected to be responsible to a small extent for inhibition of insulin release. Calmodulin-sensitive enzymes, which ifinhibited could lead to stimulation ofrelease, include cyclic nucleotide phosphodiesterase and Ca++-ATPase. These and other potential sites for inhibition by trifluoperazine remain to be investigated.
The most important conclusions from these results are that (a) calmodulin appears to be involved in stimulus-secretion coupling for glucose and glyceraldehyde-induced insulin release; (b) the two effects of glucose to stimulate insulin release, and to potentiate release in the presence of IBMX, can be dissociated by trifluoperazine; stimulation of release is calmodulin dependent, whereas the potentiating effect is calmodulin independent; (c) calmodulin does not seem to be involved in stimulus-secretion coupling after the elevation of cytosol Ca++, nor in the process of exocytosis itself. ACKNOWLEDGMENT This work was supported by a research grant from the American Diabetes Association.
